AGVHD
Clinical trials for AGVHD explained in plain language.
Never miss a new study
Get alerted when new AGVHD trials appear
Sign up with your email to follow new studies for AGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to stop deadly immune attack after stem cell transplant
Disease control Recruiting nowThis study tests an experimental drug called BPC2001 to prevent acute graft-versus-host disease (aGVHD) in 50 adults receiving a half-matched stem cell transplant for blood cancers. Participants get BPC2001 plus standard care, and researchers track how many develop aGVHD by day 1…
Matched conditions: AGVHD
Phase: PHASE2 • Sponsor: BioPhoenix Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Double donor transplant trial aims to boost leukemia survival
Disease control Recruiting nowThis study tests whether using stem cells from both a half-matched family donor and a cord blood donor can improve survival for people with high-risk blood cancers like leukemia or myelodysplastic syndromes. About 36 participants will receive the transplant and be followed for up…
Matched conditions: AGVHD
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:53 UTC